CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-09 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +54,000 | 54,000 | ||
| 2026-02-04 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +72,000 | 72,000 | ||
| 2025-04-27 | Lamb Lawrence EVP and CSO | Returned to the company · Series B Warrants (right to buy) | −1,639 | 0 | ||
| 2025-04-27 | Lamb Lawrence EVP and CSO | Grant or award · Series B Warrants (right to buy) | +1,639 | 1,639 | ||
| 2025-02-05 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +306,750 | 306,750 | ||
| 2024-12-19 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +286,899 | 286,899 | ||
| 2024-09-04 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-02-07 | Lamb Lawrence EVP AND CSO | Grant or award · Employee Stock Option (right to buy) | +169,000 | 169,000 | ||
| 2023-12-13 | Lamb Lawrence EVP and CSO | Grant or award | +1,639 | 101,369 | ||
| 2023-12-13 | Lamb Lawrence EVP and CSO | Grant or award · Series A Warrants (right to buy) | +1,639 | 1,639 | ||
| 2023-12-13 | Lamb Lawrence EVP and CSO | Grant or award · Series B Warrants (right to buy) | +1,639 | 1,639 | ||
| 2023-06-21 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +77,600 | 77,600 | ||
| 2023-04-14 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-10-21 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +62,826 | 62,826 | ||
| 2022-08-16 | Lamb Lawrence EVP and CSO | Purchase | +526 | $1.90 | $999 | 99,730 |
| 2022-05-05 | Lamb Lawrence EVP and CSO | Exercise or conversion | +26,204 | $1.07 | $28K | 99,204 |
| 2022-05-05 | Lamb Lawrence EVP and CSO | Exercise or conversion · Employee Stock Option (right to buy) | −26,204 | 1,171 | ||
| 2022-02-15 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2021-08-03 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +22,082 | 83,582 | ||
| 2021-07-29 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +61,500 | 61,500 |
Page 1 of 1 · 20 trades